Markets:

Overview

News

Currencies

International

Treasuries

Chemed Corp (NY:CHE)

410.99 -13.17 (-3.10%)

Official Closing Price Updated: 7:00 PM EST, Mar 4, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Chemed Corp

< Previous 1 2 3 4 5 Next >

Why Chemed (CHE) Shares Are Plunging Today

February 26, 2026

Shares of healthcare services company Chemed Corporation (NYSE:CHE) fell 15.6% in the afternoon session after the company reported financial results for the fourth quarter of 2025 that missed Wall...

Via StockStory

Chemed (CHE) Q4 2025 Earnings Call Transcript ↗

February 26, 2026

Chemed (CHE) Q4 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Chemed Corp. (NYSE:CHE) Shares Drop on Q4 Earnings and Revenue Miss ↗

February 25, 2026

Via Chartmill

Chemed (NYSE:CHE) Reports Sales Below Analyst Estimates In Q4 CY2025 Earnings, Stock Drops 14.7%

February 25, 2026

Healthcare services company Chemed Corporation (NYSE:CHE) fell short of the market’s revenue expectations in Q4 CY2025, with sales flat year on year at $639.3 million. Its non-GAAP profit of $6.42 per...

Via StockStory

Earnings Scheduled For October 28, 2025 ↗

October 28, 2025

Via Benzinga

Earnings Outlook For Chemed ↗

October 27, 2025

Via Benzinga

Chemed (CHE) To Report Earnings Tomorrow: Here Is What To Expect

February 23, 2026

Healthcare services company Chemed Corporation (NYSE:CHE) will be reporting earnings this Wednesday afternoon. Here’s what to look for.

Via StockStory

Topics Artificial Intelligence World Trade

1 Cash-Producing Stock to Consider Right Now and 2 We Find Risky

February 17, 2026

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

Via StockStory

Topics Economy

3 Reasons to Sell CHE and 1 Stock to Buy Instead

February 16, 2026

Chemed trades at $473.22 per share and has stayed right on track with the overall market, gaining 6.4% over the last six months. At the same time, the S&P 500 has returned 6%.

Via StockStory

Topics Stocks

Chemed Stock Down 15% in a Year as One Fund Builds a $5.56 Million Stake ↗

February 16, 2026

Chemed Corporation delivers hospice care and essential home services nationwide through its VITAS and Roto-Rooter segments.

Via The Motley Fool

Topics Regulatory Compliance

1 Profitable Stock on Our Watchlist and 2 That Underwhelm

February 08, 2026

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my...

Via StockStory

3 Healthcare Stocks We Steer Clear Of

February 05, 2026

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 18.6% over...

Via StockStory

Topics Stocks

1 Small-Cap Stock to Target This Week and 2 We Avoid

January 26, 2026

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside...

Via StockStory

3 Low-Volatility Stocks We Find Risky

January 25, 2026

Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies.

Via StockStory

Why Chemed (CHE) Shares Are Sliding Today

January 22, 2026

Shares of healthcare services company Chemed Corporation (NYSE:CHE) fell 4.2% in the afternoon session after Jefferies downgraded the stock to 'Hold' from 'Buy' and slashed its price target.

Via StockStory

1 of Wall Street’s Favorite Stock to Consider Right Now and 2 Facing Challenges

December 23, 2025

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,...

Via StockStory

3 Out-of-Favor Stocks We Think Twice About

December 08, 2025

Rock-bottom prices don't always mean rock-bottom businesses. The stocks we're examining today have all touched their 52-week lows, creating a classic investor's dilemma: bargain opportunity or value...

Via StockStory

Topics Bonds

3 Small-Cap Stocks We Approach with Caution

December 01, 2025

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a...

Via StockStory

Senior Health, Home Health & Hospice Stocks Q3 Highlights: Chemed (NYSE:CHE)

November 23, 2025

As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the senior health, home health & hospice industry, including Chemed (NYSE:CHE) and its...

Via StockStory

Topics Economy

Natera, Amneal, Chemed, The Pennant Group, and HCA Healthcare Shares Are Soaring, What You Need To Know

November 21, 2025

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated...

Via StockStory

Topics Economy

Senior Health, Home Health & Hospice Stocks Q3 Highlights: Chemed (NYSE:CHE)

November 20, 2025

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how senior health, home health & hospice stocks fared in Q3,...

Via StockStory

Topics Economy

5 Revealing Analyst Questions From Chemed’s Q3 Earnings Call

November 04, 2025

Chemed’s third quarter was marked by continued operational challenges in both the VITAS and Roto-Rooter businesses, resulting in a negative market reaction. Management attributed the margin compression...

Via StockStory

Topics Earnings

Schwartz Offloads 28,000 Chemed (CHE) Shares Valued at $13 Million ↗

November 02, 2025

Schwartz Offloads 28,000 Chemed (CHE) Shares Valued at $13 Million

Via The Motley Fool

Topics Regulatory Compliance

EULAV Asset Management Unloads $13 Million of Chemed (NYSE: CHE) Stock: Should Investors Sell Too? ↗

October 30, 2025

EULAV Asset Management Unloads $13 Million of Chemed (NYSE: CHE) Stock: Should Investors Sell Too?

Via The Motley Fool

CHE Q3 CY2025 Deep Dive: Margin Pressure Persists Despite Operational Progress in Core Segments

October 29, 2025

Healthcare services company Chemed Corporation (NYSE:CHE) met Wall Streets revenue expectations in Q3 CY2025, with sales up 3.1% year on year to $624.9 million. Its non-GAAP profit of $5.27 per share...

Via StockStory

Why Are Chemed (CHE) Shares Soaring Today

October 29, 2025

Shares of healthcare services company Chemed Corporation (NYSE:CHE) jumped 8.5% in the afternoon session after investors looked past a third-quarter earnings miss and focused instead on the company's...

Via StockStory

Topics Earnings

Caterpillar Posts Upbeat Q3 Results, Joins United Therapeutics, Centene, Fortive And Other Big Stocks Moving Higher On Wednesday ↗

October 29, 2025

Via Benzinga

Chemed’s (NYSE:CHE) Q3 Earnings Results: Revenue In Line With Expectations

October 28, 2025

Healthcare services company Chemed Corporation (NYSE:CHE) met Wall Street’s revenue expectations in Q3 CY2025, with sales up 3.1% year on year to $624.9 million. Its non-GAAP profit of $5.27 per share...

Via StockStory

Chemed (CHE) Q3 Earnings: What To Expect

October 26, 2025

Healthcare services company Chemed Corporation (NYSE:CHE) will be announcing earnings results this Tuesday after market hours. Here’s what you need to know.

Via StockStory

Topics Artificial Intelligence

1 Cash-Producing Stock with Competitive Advantages and 2 We Brush Off

October 14, 2025

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

Via StockStory

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.